Further studies should reveal the utility of MMR genes and miRNAs as diagnostic biomarkers and as a tool for novel diagnostic and therapeutic approaches in lung and head and neck squamous cell carcinomas. This evidence concerns the gene MRC1 and head and neck squamous cell carcinoma.